Home>News> Pfizer Japan drawn into valsartan recall after finding API from Mylan is tainted

Pfizer Japan drawn into valsartan recall after finding API from Mylan is tainted

The global recall of valsartan has now extended to Pfizer and to Japan, via Mylan and India.
 
According to a translated copy of its announcement, Pfizer’s Tokyo-based Japanese subsidiary said it is recalling from the country five lots of its blood pressure combo drug Amubaro because its API contains impurities that are probable carcinogens. The recall began Thursday.

Tags: